Celyad to Host Key Opinion Leader Meeting on CAR-T Therapy for … – Markets Insider
|
Celyad to Host Key Opinion Leader Meeting on CAR-T Therapy for …
Markets Insider Celyad (Paris:CYAD) (Brussels:CYAD) (Euronext Brussels and Paris, and NASDAQ: CYAD), a clinical-stage biopharmaceutical company, today announced that it will host a Key Opinion Leader luncheon on the topic of CYAD-01 (CAR-T NKG2D) cell therapy for the … |
